Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

A mouse model for adolescent alcohol abuse: stunted growth and effects in brain.

Huang C, Titus JA, Bell RL, Kapros T, Chen J, Huang R.

Alcohol Clin Exp Res. 2012 Oct;36(10):1728-37. doi: 10.1111/j.1530-0277.2012.01759.x. Epub 2012 Mar 20.

PMID:
22433022
2.

Does the inclusion criterion of women's aggression as opposed to their victimization result in samples that differ on key dimensions of intimate partner violence?

Sullivan TP, Titus JA, Holt LJ, Swan SC, Fisher BS, Snow DL.

Violence Against Women. 2010 Jan;16(1):84-98. doi: 10.1177/1077801209353575.

3.

Isolation of murine and human immunoglobulin m and murine immunoglobulin D.

Andrew SM, Titus JA, Amin A, Coico R.

Curr Protoc Immunol. 2009 Apr;Chapter 2:Unit 2.9. doi: 10.1002/0471142735.im0209s85.

PMID:
19347846
4.

Purification of immunoglobulin M and immunoglobulin D.

Andrew SM, Titus JA, Coico R, Amin A.

Curr Protoc Immunol. 2001 May;Chapter 2:Unit 2.9. doi: 10.1002/0471142735.im0209s21. Review.

PMID:
18432773
5.

Fragmentation of immunoglobulin G.

Andrew SM, Titus JA.

Curr Protoc Immunol. 2001 May;Chapter 2:Unit 2.8. doi: 10.1002/0471142735.im0208s21.

PMID:
18432772
6.

Purification of immunoglobulin G.

Andrew SM, Titus JA.

Curr Protoc Immunol. 2001 May;Chapter 2:Unit 2.7. doi: 10.1002/0471142735.im0207s21. Review.

PMID:
18432771
7.

Fragmentation of immunoglobulin M.

Andrew SM, Titus JA.

Curr Protoc Immunol. 2001 May;Chapter 2:Unit 2.10A. doi: 10.1002/0471142735.im0210as38.

PMID:
18432762
8.

Dialysis and concentration of protein solutions.

Andrew SM, Titus JA, Zumstein L.

Curr Protoc Immunol. 2001 May;Appendix 3:Appendix 3H. doi: 10.1002/0471142735.ima03hs21.

PMID:
18432660
9.

Fragmentation of immunoglobulin G.

Andrew SM, Titus JA.

Curr Protoc Cell Biol. 2003 Feb;Chapter 16:Unit 16.4. doi: 10.1002/0471143030.cb1604s17.

PMID:
18228421
10.

Purification of immunoglobulin G.

Andrew SM, Titus JA.

Curr Protoc Cell Biol. 2001 May;Chapter 16:Unit 16.3. doi: 10.1002/0471143030.cb1603s05.

PMID:
18228335
11.

Dialysis and concentration of protein solutions.

Andrew SM, Titus JA, Zumstein L.

Curr Protoc Cell Biol. 2001 May;Appendix 3:Appendix 3C. doi: 10.1002/0471143030.cba03cs04.

PMID:
18228285
12.

Dialysis and concentration of protein solutions.

Andrew SM, Titus JA, Zumstein L.

Curr Protoc Toxicol. 2002 Feb;Appendix 3:A.3H.1-5. doi: 10.1002/0471140856.txa03hs10.

PMID:
20976673
13.

CD38 triggers cytotoxic responses in activated human natural killer cells.

Sconocchia G, Titus JA, Mazzoni A, Visintin A, Pericle F, Hicks SW, Malavasi F, Segal DM.

Blood. 1999 Dec 1;94(11):3864-71.

14.

Targeted adenovirus-mediated gene delivery to T cells via CD3.

Wickham TJ, Lee GM, Titus JA, Sconocchia G, Bakács T, Kovesdi I, Segal DM.

J Virol. 1997 Oct;71(10):7663-9.

15.

Signaling pathways regulating CD44-dependent cytolysis in natural killer cells.

Sconocchia G, Titus JA, Segal DM.

Blood. 1997 Jul 15;90(2):716-25.

16.

CD44 is a cytotoxic triggering molecule on human polymorphonuclear cells.

Pericle F, Sconocchia G, Titus JA, Segal DM.

J Immunol. 1996 Nov 15;157(10):4657-63.

PMID:
8906846
17.
18.

A single-chain bispecific Fv2 molecule produced in mammalian cells redirects lysis by activated CTL.

Jost CR, Titus JA, Kurucz I, Segal DM.

Mol Immunol. 1996 Feb;33(2):211-9.

PMID:
8649442
19.
20.

Alternative triggering molecules and single chain bispecific antibodies.

Segal DM, Sconocchia G, Titus JA, Jost CR, Kurucz I.

J Hematother. 1995 Oct;4(5):377-82. Review.

PMID:
8581372
21.

Redirection of cellular cytotoxicity. A two-step approach using recombinant single-chain Fv molecules.

George AJ, Titus JA, Jost CR, Kurucz I, Perez P, Andrew SM, Nicholls PJ, Huston JS, Segal DM.

Cell Biophys. 1995 Jun;26(3):153-65. Review.

PMID:
8521448
22.

Retargeting of CTL by an efficiently refolded bispecific single-chain Fv dimer produced in bacteria.

Kurucz I, Titus JA, Jost CR, Jacobus CM, Segal DM.

J Immunol. 1995 May 1;154(9):4576-82.

PMID:
7536774
23.

Bispecific antibodies retarget murine T cell cytotoxicity against syngeneic breast cancer in vitro and in vivo.

Moreno MB, Titus JA, Cole MS, Tso JY, Le N, Paik CH, Bakács T, Zacharchuk CM, Segal DM, Wunderlich JR.

Cancer Immunol Immunother. 1995 Mar;40(3):182-90.

PMID:
7728777
24.

CD44 is a cytotoxic triggering molecule in human peripheral blood NK cells.

Sconocchia G, Titus JA, Segal DM.

J Immunol. 1994 Dec 15;153(12):5473-81.

PMID:
7527443
25.

Mammalian expression and secretion of functional single-chain Fv molecules.

Jost CR, Kurucz I, Jacobus CM, Titus JA, George AJ, Segal DM.

J Biol Chem. 1994 Oct 21;269(42):26267-73.

26.

Redirection of T cell-mediated cytotoxicity by a recombinant single-chain Fv molecule.

George AJ, Titus JA, Jost CR, Kurucz I, Perez P, Andrew SM, Nicholls PJ, Huston JS, Segal DM.

J Immunol. 1994 Feb 15;152(4):1802-11.

PMID:
8120389
27.

Improved processes for the production and isolation of dynemicin A and large-scale fermentation in a 10,000-liter fermentor.

Lam KS, Titus JA, Dabrah TT, Kimball DL, Veitch JM, Gustavson DR, Compton BJ, Matson JA, Forenza S, Ross J, et al.

J Ind Microbiol. 1992 Nov;11(1):7-12.

PMID:
1369016
28.

Targeting of anti-tumor responses with bispecific antibodies.

Segal DM, Qian JH, Mezzanzanica D, Garrido MA, Titus JA, Andrew SM, George AJ, Jost CR, Perez P, Wunderlich JR.

Immunobiology. 1992 Aug;185(2-4):390-402. Review.

PMID:
1452212
29.

Targeted cytokine production.

Segal DM, Qian JH, Titus JA, Moreno MB, George AJ, Jost CR, Kurucz I, el-Gamil M, Wunderlich JR.

Int J Cancer Suppl. 1992;7:36-8. Review.

PMID:
1428400
30.

Cytokine release by peripheral blood lymphocytes targeted with bispecific antibodies, and its role in blocking tumor growth.

Segal DM, Qian JH, Andrew SM, Titus JA, Mezzanzanica D, Garrido MA, Wunderlich JR.

Ann N Y Acad Sci. 1991 Dec 30;636:288-94. Review. No abstract available.

PMID:
1793216
31.
32.

Human peripheral blood lymphocytes targeted with bispecific antibodies release cytokines that are essential for inhibiting tumor growth.

Qian JH, Titus JA, Andrew SM, Mezzanzanica D, Garrido MA, Wunderlich JR, Segal DM.

J Immunol. 1991 May 1;146(9):3250-6.

PMID:
1826709
33.

Effectors of targeted cellular cytotoxicity.

Segal DM, Garrido MA, Qian JH, Mezzanzanica D, Andrew S, Perez P, Kurucz I, Valdayo MJ, Titus JA, et al.

Mol Immunol. 1990 Dec;27(12):1339-42. Review. No abstract available. Erratum in: Mol Immunol 1991 Jun;28(6):683. Mezzananica D [corrected to Mezzanzanica D].

PMID:
2274063
34.

Improvement of glidobactin A production by Polyangium brachysporum.

Titus JA, Roundy CA.

J Ind Microbiol. 1990 Nov;6(3):215-8.

PMID:
1367482
35.

Targeting human T-lymphocytes with bispecific antibodies to react against human ovarian carcinoma cells growing in nu/nu mice.

Garrido MA, Valdayo MJ, Winkler DF, Titus JA, Hecht TT, Perez P, Segal DM, Wunderlich JR.

Cancer Res. 1990 Jul 15;50(14):4227-32.

36.

Targeted cytotoxic cells in human peripheral blood lymphocytes.

Garrido MA, Perez P, Titus JA, Valdayo MJ, Winkler DF, Barbieri SA, Wunderlich JR, Segal DM.

J Immunol. 1990 Apr 15;144(8):2891-8.

PMID:
1691221
37.

Refocusing the immune system to react with human tumors by targeting human lymphocytes with bispecific antibodies.

Garrido MA, Valdayo MJ, Winkler DF, Titus JA, Hecht TT, Perez P, Segal DM, Wunderlich JR.

Dev Biol Stand. 1990;71:33-42.

PMID:
2144834
38.

Targeted cytotoxic cells as a novel form of cancer immunotherapy.

Segal DM, Garrido MA, Perez P, Titus JA, Winkler DA, Ring DB, Kaubisch A, Wunderlich JR.

Mol Immunol. 1988 Nov;25(11):1099-103. No abstract available.

PMID:
3265476
39.

Targeting of cytotoxic cells against tumors with heterocrosslinked, bispecific antibodies.

Segal DM, Qian JH, Garrido MA, Perez P, Winkler DF, Wunderlich JR, Snider DP, Valdayo MJ, Titus JA.

Princess Takamatsu Symp. 1988;19:323-31.

PMID:
3269363
40.
41.
42.

Human T cells targeted with anti-T3 cross-linked to antitumor antibody prevent tumor growth in nude mice.

Titus JA, Garrido MA, Hecht TT, Winkler DF, Wunderlich JR, Segal DM.

J Immunol. 1987 Jun 1;138(11):4018-22.

PMID:
3108382
43.

Fluorescence flow cytometry in the study of lymphoid cell receptors.

Segal DM, Titus JA, Stephany DA.

Methods Enzymol. 1987;150:478-92. No abstract available.

PMID:
3431433
44.

Targeting of cytotoxic cells with cross-linked antibody heteroaggregates.

Segal DM, Perez P, Karpovsky B, Titus JA.

Mol Immunol. 1986 Nov;23(11):1211-4. No abstract available.

PMID:
3493425
45.

Specific lysis of human tumor cells by T cells coated with anti-T3 cross-linked to anti-tumor antibody.

Perez P, Titus JA, Lotze MT, Cuttitta F, Longo DL, Groves ES, Rabin H, Durda PJ, Segal DM.

J Immunol. 1986 Oct 1;137(7):2069-72.

PMID:
2944946
46.
48.

Nutrient effects on anthracycline production by Streptomyces peucetius in a defined medium.

Dekleva ML, Titus JA, Strohl WR.

Can J Microbiol. 1985 Mar;31(3):287-94.

PMID:
3859358
49.
50.

Characterization of murine lymphocyte IgE receptors by flow microfluorometry.

Katona IM, Urban JF Jr, Titus JA, Stephany DA, Segal DM, Finkelman FD.

J Immunol. 1984 Sep;133(3):1521-8.

PMID:
6235289

Supplemental Content

Loading ...
Support Center